AMT-260 is a one-time administered, in vivo gene therapy candidate intended to reduce or eliminate seizures in people with drug-resistant mesial temporal lobe epilepsy. AMT-260 is designed to ...

Inspiration for this work has come from a group of patients who have a brain disorder called temporal lobe epilepsy. In a minority of patients, this condition induces bizarre religious hallucinations ...

Another, caused by damage to the temporal lobes (located on either side of the head near the ears) causes people to lose vocabulary, speak with difficulty, or forget what everyday objects are used ...

Over the past day, Ukraine’s defense forces eliminated another 1,020 Russian occupiers. As a result, the total personnel losses of the Russian army since the beginning of the full-scale invasion ...

ST. LOUIS — A group of legal professionals is asking state and city leaders to remove St. Louis Sheriff Alfred Montgomery from office. The Holy Joe Society, a local organization that says it ...

Introduction: Temporal lobe epilepsy (TLE) patients often experience exacerbation of seizures following COVID-19 infection, a condition referred to as post-COVID-19 active TLE. Although ...

A. Good works done in mortal sin profit us by obtaining for us the grace to repent and sometimes temporal blessings. Mortal sin deprives us of all our merit, nevertheless God will bestow gifts for ...

np.unimaas.nl Objectives: To investigate whether medial temporal lobe atrophy predicted outcome in patients with minor cognitive impairment and whether assessment of the medial temporal lobe could ...

“These early results from the first trial participant are very encouraging and support our belief that AMT-260 has the potential to be a valuable treatment alternative for people living with ...